PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions. Sahu A, Gill M, Hermawan A, Shinde A, et al. J Invest Dermatol 2026 May 12:S0022-202X(26)01198.

Read + Share

Amedeo Smart

Independent Medical Education

Sahu A, Gill M, Hermawan A, Shinde A, et al. PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions. J Invest Dermatol 2026 May 12:S0022-202X(26)01198.
PMID: 42128048